summari updat forecast ahead
compani anticip report full year guidanc
come week increas total revenu forecast
repres growth organ ex-
seprafilm acquisit ex-fx report lower
ep forecast penni still ahead
consensu estim updat model includ
follow bax preliminari guidanc reported/ex-fx
sale growth vs previou forecast report
ex-fx adjust oper margin complet
seprafilm acquisit add estim sale
ep estim higher sale infus
system account alari shiphold increment
fx headwind compar month ago lower net
incom non-oper plan report full result
give detail guidanc march ep estim
increas
chang revenu model differ
preliminari guidanc underli basi ex-seprafilm pump
benefit increas ex-fx sale growth estim
latter toward high-end
guidanc rang new growth also higher
revenu base follow bax preliminari report addit
new revenu forecast also includ seprafilm
revenu assum benefit shiphold
togeth two increment factor add top-lin
growth exclud bax preliminari guidanc issu
januari howev latest fx analysi also point wors
currenc environ compar month ago fx headwind
vs previou bax preliminari sale guidanc
growth report ex-fx basi expect
updat guidanc includ seprafilm deal
close manag may take conserv approach
exclud potenti benefit pump shiphold
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud one-tim item adjust
compani data secur llc estim reuter
continu previou page
well posit benefit bdx shiphold new lvp larg volum parenter
syring pump platform set launch year believ best posit gain increment
share bdx alari pump shiphold current hold nearli one-quart us lvp pump
market repres half non-bdx market base bdx estim lost pump sale
assum regain alari return estim
gain share sale custom await alari return
ad addit sale us infus system forecast includ equip
set although bax pca patient control analges pump expect understand
rel small part overal us pump market
chang rest guid adjust oper margin
forecast high-end guidanc rang two key reason first seprafilm deal
margin accret accord math guidanc exclud impact deal
second believ opportunist addit lvp pump set sale result bdx shiphold
also add margin yet guid oper line lower
net non-oper incom estim although bax recent
restat figur give us precis adjust magnitud chang suggest
model line conserv model account meaning earn
benefit share repurchas
price target nc
price target base equal weight ev/ebtida dcf p/e/g risk
thesi includ uncertainti intern investig unexpect competit headwind could
slow restructur effort signific delay new launch
believ deliv guidanc acceler sale growth margin expans ep
growth
baxter global medic product compani focus hospit product renal compani
report sale billion ex-fx growth
